$~0
0[0.00%]
Last update: 2:43PM Get Real Time Here
GlobeImmune
(OTCEM:GBIM)Latest News for GlobeImmune Stock (OTC:GBIM)
GlobeImmune Stock (OTC: GBIM)
Categories: All
Wednesday, July 06, 2016
- Mid-Afternoon Market Update: Crude Oil Up 2%; Supercom Shares Drop After Q1 ResultsBenzinga - Jul 6, 2016, 2:31PM
- 10 Biggest Mid-Day Losers For WednesdayBenzinga - Jul 6, 2016, 12:52PM
- Mid-Day Market Update: U.S. Stocks Turn Positive; Nortek Shares Surge Following Acquisition NewsBenzinga - Jul 6, 2016, 12:08PM
- Mid-Morning Market Update: Markets Open Lower; Walgreens Profit Tops ExpectationsBenzinga - Jul 6, 2016, 10:08AM
- 12 Stocks Moving In Wednesday's Pre-Market SessionBenzinga - Jul 6, 2016, 8:22AM
Tuesday, July 05, 2016
- GlobeImmune Shares Resume Trading, Down $0.80 After HoursBenzinga - Jul 5, 2016, 5:07PM
- GlobeImmune Shares To Resume Trading At 5pm EDTBenzinga - Jul 5, 2016, 4:39PM
- GlobeImmune Reports Delisting and Deregistration of Common StockBenzinga - Jul 5, 2016, 4:30PM
- GlobeImmune Shares Halted News PendingBenzinga - Jul 5, 2016, 4:25PM
Monday, June 20, 2016
Friday, June 17, 2016
Monday, June 13, 2016
Thursday, May 12, 2016
Wednesday, March 16, 2016
Wednesday, February 24, 2016
Wednesday, February 03, 2016
Tuesday, December 01, 2015
Friday, August 14, 2015
Thursday, August 13, 2015
Thursday, June 11, 2015
Wednesday, June 10, 2015
- Stocks Hitting 52-Week LowsBenzinga - Jun 10, 2015, 10:05AM
- Morning Market LosersBenzinga - Jun 10, 2015, 9:45AM
- GlobeImmune Shares Fall 27% Premarket Following Announcement of Evaluating pf Strategic AlternativesBenzinga - Jun 10, 2015, 9:24AM
- US Stock Futures Signal Higher Start On Wall StreetBenzinga - Jun 10, 2015, 7:30AM
- GlobeImmune Evaluating Strategic Alternatives; Not Expected to Impact Ongoing Clinical TrialsBenzinga - Jun 10, 2015, 6:33AM
Wednesday, May 27, 2015
- Stocks Hitting 52-Week LowsBenzinga - May 27, 2015, 10:17AM
- Morning Market LosersBenzinga - May 27, 2015, 9:53AM
- US Stock Futures Edge Higher; Costco Earnings In FocusBenzinga - May 27, 2015, 7:18AM
- UPDATE: GlobeImmune Reports Patients Treated with Highest Dose of GS-4774 Plus Ongoing Oral Antiviral Therapy did Not Show Reduction in Hepatitis B Surface Antigen (HBsAg) at Week 24Benzinga - May 27, 2015, 6:35AM
- GlobeImmune Announces Top Line Results From GS-4774 Phase 2 Trial in Virally-Suppressed Chronic HBV PatientsBenzinga - May 27, 2015, 6:33AM